Pay in 4 interest-free payments of $5.26 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Combined therapy with a low dose (75 mg/kg) of diazoxide and the alkylating agents melphalan or N-(2-chloroethyl)-N-nitrosocarbamoyl (CNC)-omega-lysine increased the therapeutic efficacy of both cytostatics up to twofold in the MNU-induced rat mammary carcinoma
Shared principles apply when framed through choice, compassion, and bio-individuality
Works effectively as an antioxidant to neutralize free radicals
Federal taxpayers fund much of Medicare, but beneficiaries also must pay copays and coinsurance
- 2
US$ 24.52
US$ 22.67
US$ 27.18
US$ 26.89
US$ 21.31
US$ 28.02
